1,203 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by May Hill Capital LLC

May Hill Capital LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,203 shares of the healthcare conglomerate's stock, valued at approximately $609,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC lifted its position in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the period. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $629.32.

Remove Ads

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $0.49 during trading hours on Wednesday, reaching $523.61. 2,368,702 shares of the company's stock traded hands, compared to its average volume of 4,265,458. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm's 50 day simple moving average is $509.06 and its 200-day simple moving average is $542.96. The stock has a market cap of $478.95 billion, a PE ratio of 33.78, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.